Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study

অনুরূপ উপাদানগুলি

• Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study
  অনুযায়ী: Klipping, Christine, অন্যান্য
  প্রকাশিত: (2012)
• Efficacy of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study
  অনুযায়ী: Strowitzki, Thomas, অন্যান্য
  প্রকাশিত: (2012)
• Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) in three indications in the People’s Republic of China: a comparison with international studies
  অনুযায়ী: Marr, Joachim, অন্যান্য
  প্রকাশিত: (2015)
• Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen)
  অনুযায়ী: Bitzer, Johannes, অন্যান্য
  প্রকাশিত: (2015)
• Adherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study
  অনুযায়ী: Wiegratz, Inka, অন্যান্য
  প্রকাশিত: (2015)